India RUO Immunoassay Market Size, Share, Opportunities, And Trends By Product Type (Immunoassay Kits, Immunoassay Reagents, Microplate Reader, Microplates, Analyzers (Automated Analyzers, Non-Automated Analyzers), Microplate Washers, Others), By Sample Type (Plasma, Blood Serum, Urine, Saliva, Cell or Tissue Culture Medium, Others), By Application (Oncology, Blood Screening and Toxicology, Infectious Disease, Cardiology, Allergy Diagnostic, Rare and Emerging Condition Diagnostic, Others), By End-User (Research and Academic Laboratories, Pharmaceutical and Biotechnology Companies), And By State - Forecasts From 2025 To 2030

India RUO Immunoassay Market Size:

The India RUO immunoassay market is expected to grow at a CAGR of 12.91% from 2025 to 2030.

India’s RUO immunoassay market is mainly driven by government support towards nurturing the innovation ecosystem. The ICMR has set up centers of excellence at seven IITs for product development, along with five ICMR Centers for Advanced Research (CAR) focused on testing, preclinical and clinical evaluation, and validation. This initiative aims to bolster the Make in India MedTech sector. 

India ranks as the fourth largest medical device market in Asia, following Japan, China, and South Korea, and is also among the top 20 medical device markets worldwide. Medical device exports from India amounted to Rs. 19,803 crore (US$ 2.40 billion) in the fiscal year 2021-2022. From April to December 2022, medical device exports reached Rs. 20,511 crore (US$ 2.49 billion). Projections by IBEF indicate that these exports are expected to grow substantially, reaching US$ 10 billion by the year 2025.   

The market is expanding, and exports are rising due to various initiatives. These include the implementation of a system for export labeling, clarification on clinical evaluation and adverse event reporting, extension of the validity of free sales certificates by state licensing authorities from 2 years to 5 years for facilitating exports, and the creation of a list of manufacturers with export licenses to facilitate easier access by regulatory authorities worldwide.

India faces a significant burden of chronic diseases like diabetes, cancer, and others. RUO immunoassays are crucial research tools for development. India’s diabetes estimates (20-79 y) were 74,194.7 in 2021 and are expected to rise to 92,973.7 by 2030 (number in 1,000s). The number of cancer cases estimated by the government was 1,496,972 in 2023 and would rise to 1,533,055 in 2024. These figures further elaborate on the necessity for research and diagnostics tools for monitoring these conditions.

Further favorable developments are also contributing to the market growth. For example, Fujirebio Holdings, Inc. and Agappe Diagnostics Ltd announced a Contract Development and Manufacturing Organization (CDMO) partnership for the Cartridge CLIA system reagents manufacturing project for the immunology equipment Mispa i60 and Mispa i121. 

The analyzers and reagents will be marketed under the Agappe brand, establishing Agappe as the first Indian company to offer a comprehensive Chemiluminescence Solution featuring locally manufactured reagents. This will provide high-quality, affordable, and unique Chemiluminescence solutions for the country.

India RUO Immunoassay Market Scope:

Report Metric	Details
India RUO Immunoassay Market Size in 2025	US$1.666 billion
India RUO Immunoassay Market Size in 2030	US$2.345 billion
Growth Rate	CAGR of 12.91%
Study Period	2020 to 2030
Historical Data	2020 to 2023
Base Year	2024
Forecast Period	2025 – 2030
Forecast Unit (Value)	USD Billion
Segmentation	Product Type Sample Type Application End-User State
Geographical Segmentation	Maharashtra, Tamil Nadu, Karnataka, Uttar Pradesh, Others
List of Major Companies in the India RUO Immunoassay Market	Hoffmann-La Roche Ltd Merck KGaA Danaher Corporation Quanterix Corporation Thermo Fisher Scientific Inc.
Customization Scope	Free report customization with purchase

 

India RUO Immunoassay Market Segmentation

By Product Type

• Immunoassay Kits
  • Enzyme-Linked Immunosorbent Assay (ELISA) Kits
    • Conventional
    • Manual
  • Radioimmunoassay (RIA Kits)
    • Conventional
    • Manual
  • Chemiluminescent Immunoassay (CLIA) Kits
• Immunoassay Reagents
• Microplate Reader
• Microplates
• Analyzers
  • Automated Analyzers
  • Non-Automated Analyzers
• Microplate Washers
• Others

By Sample Type

• Plasma
• Blood Serum
• Urine
• Saliva
• Cell or Tissue Culture Medium
• Others

By Application

• Oncology
• Blood Screening and Toxicology
• Infectious Disease
• Cardiology
• Allergy Diagnostic
• Rare and Emerging Condition Diagnostic
• Others

By End-User

• Research and Academic Laboratories
• Pharmaceutical and Biotechnology Companies

By State

• Maharashtra
• Tamil Nadu
• Karnataka
• Uttar Pradesh
• Others

---

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

4.1. Product Pipeline

5. INDIA RUO IMMUNOASSAY MARKET BY PRODUCT TYPE

5.1. Introduction

5.2. Immunoassay Kits

5.2.1. Enzyme-Linked Immunosorbent Assay (ELISA) Kits

5.2.1.1. Conventional 

5.2.1.2. Manual

5.2.2. Radioimmunoassay (RIA Kits)

5.2.2.1. Conventional 

5.2.2.2. Manual

5.2.3. Chemiluminescent Immunoassay (CLIA) Kits

5.3. Immunoassay Reagents

5.4. Microplate Reader

5.5. Microplates

5.6. Analyzers

5.6.1. Automated Analyzers

5.6.2. Non-Automated Analyzers

5.7. Microplate Washers

5.8. Others

6. INDIA RUO IMMUNOASSAY MARKET BY SAMPLE TYPE

6.1. Introduction

6.2. Plasma 

6.3. Blood Serum

6.4. Urine

6.5. Saliva

6.6. Cell or Tissue Culture Medium

6.7. Others

7. INDIA RUO IMMUNOASSAY MARKET BY APPLICATION

7.1. Introduction

7.2. Oncology

7.3. Blood Screening and Toxicology

7.4. Infectious Disease

7.5. Cardiology

7.6. Allergy Diagnostic

7.7. Rare and Emerging Condition Diagnostic

7.8. Others

8. INDIA RUO IMMUNOASSAY MARKET BY END-USER

8.1. Introduction

8.2. Research and Academic Laboratories

8.3. Pharmaceutical and Biotechnology Companies

9. INDIA RUO IMMUNOASSAY MARKET BY STATE

9.1. Introduction

9.2. Maharashtra

9.2.1. By Product Type

9.2.2. By Sample Type

9.2.3. By Application

9.2.4. By End-User

9.3. Tamil Nadu

9.3.1. By Product Type

9.3.2. By Sample Type

9.3.3. By Application

9.3.4. By End-User

9.4. Karnataka

9.4.1. By Product Type

9.4.2. By Sample Type

9.4.3. By Application

9.4.4. By End-User

9.5. Uttar Pradesh

9.5.1. By Product Type

9.5.2. By Sample Type

9.5.3. By Application

9.5.4. By End-User

9.6. Others

9.6.1. By Product Type

9.6.2. By Sample Type

9.6.3. By Application

9.6.4. By End-User

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

10.1. Major Players and Strategy Analysis

10.2. Market Share Analysis

10.3. Mergers, Acquisitions, Agreements, and Collaborations

10.4. Competitive Dashboard

11. COMPANY PROFILES

11.1. F. Hoffmann-La Roche Ltd

11.2. Merck KGaA

11.3. Danaher Corporation

11.4. Quanterix Corporation

11.5. Thermo Fisher Scientific Inc. 

11.6. QuidelOrtho Corporation

11.7. Becton Dickinson

11.8. Fujirebio Inc. (H.U. Group Holdings)

11.9. Getein BioTech Inc

12. APPENDIX

12.1. Currency 

12.2. Assumptions

12.3. Base and Forecast Years Timeline

12.4. Key benefits for the stakeholders

12.5. Research Methodology 

12.6. Abbreviations 

Hoffmann-La Roche Ltd

Merck KGaA

Danaher Corporation

Quanterix Corporation

Thermo Fisher Scientific Inc. 

QuidelOrtho Corporation

Becton Dickinson

Fujirebio Inc. (H.U. Group Holdings)

Getein BioTech Inc